www.sandoz.com
Open in
urlscan Pro
2606:4700:4400::ac40:942f
Public Scan
URL:
https://www.sandoz.com/
Submission: On October 14 via manual from DE — Scanned from CA
Submission: On October 14 via manual from DE — Scanned from CA
Form analysis
0 forms found in the DOMText Content
About Sandoz * What we do * Our purpose and ambition * Our Code of Ethics * Annual General Meeting * Corporate Assurance * Integrated Assurance & Resilience * Ethics and Compliance * SpeakUp Office * Data Privacy * Human Rights * Third Party Risk Management * Company Overview * Board of Directors * Sandoz Leadership * Corporate Governance * ESG * News Archive * Our History Business * Manufacturing, Quality and Supply * Biosimilars * Value of Biosimilars * Sandoz Biosimilar Portfolio * Sandoz Biosimilar Pipeline * Biologics bring breakthroughs * Science of Biosimilars * Information for Patients * Generics * B2B People & Culture * Board of Directors * Sandoz Leadership * Our culture * Diversity, Equity and Inclusion * Associate stories Impact * Access * Environment * People * Governance * Partnerships for Impact Media * News * Publications * Media Contacts * Stay up-to-date Investors Careers * Job Search * Our Culture * Our Teams * Sandoz Commercial Operations * People & Organization * Sandoz Technology * Personal Growth & Learning at Sandoz * Flexible-Hybrid Working at Sandoz * Diversity & Inclusion * Rewards & Recognition * Well-being About Sandoz About Sandoz What we do What we do Our purpose and ambition Our purpose and ambition Our Code of Ethics Our Code of Ethics Annual General Meeting Annual General Meeting Corporate Assurance Corporate Assurance Integrated Assurance & Resilience Integrated Assurance & Resilience Ethics and Compliance Ethics and Compliance SpeakUp Office SpeakUp Office Data Privacy Data Privacy Human Rights Human Rights Third Party Risk Management Third Party Risk Management Company Overview Company Overview Board of Directors Board of Directors Sandoz Leadership Sandoz Leadership Corporate Governance Corporate Governance ESG ESG News Archive News Archive Our History Our History Business Business Manufacturing, Quality and Supply Manufacturing, Quality and Supply Biosimilars Biosimilars Value of Biosimilars Value of Biosimilars Sandoz Biosimilar Portfolio Sandoz Biosimilar Portfolio Sandoz Biosimilar Pipeline Sandoz Biosimilar Pipeline Biologics bring breakthroughs Biologics bring breakthroughs Science of Biosimilars Science of Biosimilars Information for Patients Information for Patients Generics Generics B2B B2B People & Culture People & Culture Board of Directors Board of Directors Sandoz Leadership Sandoz Leadership Our culture Our culture Diversity, Equity and Inclusion Diversity, Equity and Inclusion Associate stories Associate stories Impact Impact Access Access Environment Environment People People Governance Governance Partnerships for Impact Partnerships for Impact Media Media News News Publications Publications Media Contacts Media Contacts Stay up-to-date Stay up-to-date Investors Investors Careers Careers Job Search Job Search Our Culture Our Culture Our Teams Our Teams Sandoz Commercial Operations Sandoz Commercial Operations People & Organization People & Organization Sandoz Technology Sandoz Technology Personal Growth & Learning at Sandoz Personal Growth & Learning at Sandoz Flexible-Hybrid Working at Sandoz Flexible-Hybrid Working at Sandoz Diversity & Inclusion Diversity & Inclusion Rewards & Recognition Rewards & Recognition Well-being Well-being Previous SANDOZ Pioneering access for patients Read more NEWS Sandoz US launches generic paclitaxel in single-dose vial, further expanding US oncology portfolio Read more NEWS Ensuring responsible access to critical antibiotics Read more NEWS Sandoz reports progress as a standalone company at its investor event in Zurich, reiterates mid-term ambitions Read more NEWS Sandoz receives FDA approval for Enzeevu™ (aflibercept-abzv), further strengthening US biosimilar position Read more SANDOZ Pioneering access for patients Read more NEWS Sandoz US launches generic paclitaxel in single-dose vial, further expanding US oncology portfolio Read more NEWS Ensuring responsible access to critical antibiotics Read more NEWS Sandoz reports progress as a standalone company at its investor event in Zurich, reiterates mid-term ambitions Read more NEWS Sandoz receives FDA approval for Enzeevu™ (aflibercept-abzv), further strengthening US biosimilar position Read more SANDOZ Pioneering access for patients Read more Next * 1 * 2 * 3 * 4 * 5 H1 2024 RESULTS Sandoz reports second-quarter sales and half-year 2024 results. Read the media release Download the half-year report Visit our investor relations website OUR BUSINESS Introducing the leading name in generic and biosimilar medicines. BIOSIMILARS We're proud to be a world leader in the development of biosimilars. Read more GENERICS Quality medicines made more affordable. Read more SANDOZ AND YOU INVESTORS Updates and resources for investors including financial information, disclosures, events, share price and reporting. Read more MEDIA Information for journalists, including media releases, statements, stories, multimedia resources and more. Read more CAREERS Find your next-level career opportunity at Sandoz and help us pioneer access for patients. Read more PATIENTS & CAREGIVERS With patients in mind, we help patients to access the medicines they need at the right time. Read more INVESTORS Updates and resources for investors including financial information, disclosures, events, share price and reporting. Read more MEDIA Information for journalists, including media releases, statements, stories, multimedia resources and more. Read more CAREERS Find your next-level career opportunity at Sandoz and help us pioneer access for patients. Read more PATIENTS & CAREGIVERS With patients in mind, we help patients to access the medicines they need at the right time. Read more INVESTORS Updates and resources for investors including financial information, disclosures, events, share price and reporting. Read more MEDIA Information for journalists, including media releases, statements, stories, multimedia resources and more. Read more CAREERS Find your next-level career opportunity at Sandoz and help us pioneer access for patients. Read more * 1 * 2 WE’D LIKE TO HEAR FROM YOU Get in touch with us today: Contact us * * KEY RESOURCES * INVESTORS * MEDIA * PATIENTS & CAREGIVERS * PARTNERS (B2B) * JOB SEEKERS * SUPPLIERS EXPLORE * CONTACTS * OUR POLICIES * TRANSPARENCY * CAREERS * SANDOZ SITE DIRECTORY TOOLS & SERVICES * REPORT ADVERSE EVENT * SPEAK UP OUR COMPANIES * 1 A PHARMA * HEXAL * LEK KEY RESOURCES KEY RESOURCES * INVESTORS * MEDIA * PATIENTS & CAREGIVERS * PARTNERS (B2B) * JOB SEEKERS * SUPPLIERS EXPLORE EXPLORE * CONTACTS * OUR POLICIES * TRANSPARENCY * CAREERS * SANDOZ SITE DIRECTORY TOOLS & SERVICES TOOLS & SERVICES * REPORT ADVERSE EVENT * SPEAK UP OUR COMPANIES OUR COMPANIES * 1 A PHARMA * HEXAL * LEK © 2024 Sandoz Group AG Terms of Use Privacy Policy Social Media Community Guidelines Copyright Licenses & Attributions This site is intended for a global audience YOUR PRIVACY IS IMPORTANT FOR US. We use cookies to enhance your experience when visiting our websites: performance cookies show us how you use this website, functional cookies remember your preferences and targeting cookies help us to share content relevant to you. Select “Accept all” for giving your consent to all cookies, select “Cookie settings” for managing the different cookies or select “Reject all” for using only strictly necessary cookies. You can change your cookie settings at any point of time by pressing the cookie settings link on the website. Cookies Settings Accept all COOKIE PREFERENCE CENTER When you visit any website, it may store or retrieve information on your browser by using cookies. The cookies are set to expire when the information is no longer needed or after a maximum period of 13 months. You can choose to allow or not to allow some specific types of cookies. Click on the different category headings below to find out more. Please note that blocking some types of cookies may impact your experience on the site and the services we are able to offer. Accept all MANAGE CONSENT PREFERENCES STRICTLY NECESSARY COOKIES Always Active These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information. Cookies Details PERFORMANCE COOKIES Performance Cookies These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Cookies Details TARGETING COOKIES Targeting Cookies These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising. Cookies Details Back Button COOKIE LIST Search Icon Filter Icon Clear checkbox label label Apply Cancel Consent Leg.Interest checkbox label label checkbox label label checkbox label label Save choices